Use of an alpha lipoic, methylsulfonylmethane, boswellia and bromelain dietary supplement (Opera®) for Aromatase inhibitor - related arthralgia management

Data: 26 Ottobre 2018

Autore: Department of Radiation Oncology, University of Florence

Use of an alpha lipoic, methylsulfonylmethane, boswellia and bromelain dietary supplement (Opera®) for Aromatase inhibitor - related arthralgia management

01/04/2017 Protocollo STOP (everolimus-induced STOmatitis Prevention trial) -ON PRESS

di GION - Coodinatore dr. C. PORTA- Policlinico S. Matteo Pavia


Prodotti in farmacia

disponibili in farmacia
e parafarmacia